IPEC Americas & IQ Consortium - FDA meeting to discuss Novel Excipients Initiative - June 4, 2015

Download
The purpose of this meeting was to allow members of IPEC/IQ an opportunity to present information related to the reasons why the current system of having all types of novel excipients only reviewed as
The purpose of this meeting was to allow members of IPEC/IQ an opportunity to present information related to the reasons why the current system of having all types of novel excipients only reviewed as part of a drug application does not facilitate the use of these novel excipients and to present concepts for possible alternatives.
2015 June 4 IPEC-IQ-FDA Novel Excipient
Adobe Acrobat Document 1.3 MB